Snowy landscapes. Starry skies. Cozy beds. This is how you embrace winter glamping in New England. For those of you who love ...

AstraZeneca has reported the first phase 3 data with its next-generation complement C5 inhibitor, gefurulimab, which could give patients with generalised myasthenia gravis (gMG) a treatment option ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.